Quality of life in nonfunctioning pituitary macroadenoma patients before and after surgical treatment

详细信息    查看全文

• 作者：Eriko Tanemura (1)
  Tetsuya Nagatani (1)
  Yuri Aimi (2)
  Yugo Kishida (3)
  Kazuhito Takeuchi (1)
  Toshihiko Wakabayashi (1)
  
• 关键词：Quality of life ; Pituitary adenoma ; Endoscopic transsphenoidal surgery ; QOL transition ; SF ; 36
• 刊名：Acta Neurochirurgica
• 出版年：2012
• 出版时间：October 2012
• 年：2012
• 卷：154
• 期：10
• 页码：1895-1902
• 全文大小：302KB
• 参考文献：1. Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M, Bungay K, Fukuhara S, Gandek B, Keller S, Razavi R, Sanson-Fisher M, Sullivan S, Wood-Dauphinee S, Wagner A, Ware JE (1992) International quality of life assessment (IQOLA) project. Qual Life Res 1:349-51 CrossRef
  2. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369-376 CrossRef
  3. Budrukkar A, Jalali R, Dutta D, Sarin R, Devlekar R, Parab S, Kakde A (2009) Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol 95:413-19 CrossRef
  4. Cappabianca P, Cavallo LM, Colao A, de Divitiis E (2002) Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 97:293-98 CrossRef
  5. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM (2006) Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 154:483-89 CrossRef
  6. Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:3717-726 CrossRef
  7. Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364-369 CrossRef
  8. Engeland WC, Arnhold MM (2005) Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 28:325-32 CrossRef
  9. Fleseriu M, Yedinak C, Campbell C, Delashaw JB (2009) Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions. J Neurosurg 110:354-58 CrossRef
  10. Freda PU, Beckers AM, Katznelson L, Molitch ME, Monitor VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:894-04 CrossRef
  11. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51:1037-044 CrossRef
  12. Fukuhara S, Suzukamo Y (2004) Manual of SF-36v2 Japanese version. Inst Health Outcome Proc Eval Res
  13. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51:1045-053 CrossRef
  14. Goldberg DP, Hillier VF (1979) A scaled version of the general health questionnaire. Psychol Med 9:139-45 CrossRef
  15. Ironside JW (2003) Best practice no. 172: pituitary gland pathology. J Clin Pathol 56:561-68 CrossRef
  16. Iwata N, Uno B, Suzuki T (1994) Psychometric properties of the 30-items version general health questionnaire in Japanese. Jpn J Psychiatry Neurol 48:547-56
  17. Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81-7 CrossRef
  18. Karabatsou K, O’Kelly C, Ganna A, Dehdashti AR, Gentili F (2008) Outcomes and quality of life assessment in patients undergoing endoscopic surgery for pituitary adenomas. Br J Neurosurg 22:630-35 CrossRef
  19. Kitamura T, Toda MA, Shima S, Sugawara M (1989) Validity of the Japanese version of the GHQ among antenatal clinic attendants. Int J Psychiatry Med 24:149-56 CrossRef
  20. Levy MJ, J?ger HR, Powell M, Matharu MS, Meeran K, Goadsby PJ (2004) Pituitary volume and headache: size is not everything. Arch Neurol 61:721-25 CrossRef
  21. McKean-Cowdin R, Varma R, Hays RD, Wu J, Choudhury F, Azen SP, Los Angeles Latino Eye Study Group (2010) Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study. Ophthalmology 117:1900-907 CrossRef
  22. Molitch ME (2009) Pituitary incidentalomas. Best Pract Pes Clin Endocrinol Metab 23:667-75 CrossRef
  23. Morita A, OkadaY KM, Hori T, Taneda M, Kirino T (2004) Development of hybrid integrated endoscope-holder system for endoscopic microsurgery. Neurosurgery 55:926-32 CrossRef
  24. Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56:1222-233 CrossRef
  25. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314:287-91 CrossRef
  26. Okamoto Y, Okamoto F, Yamada S, Honda M, Hiraoka T, Oshika T (2010) Vision-related quality of life after transsphenoidal surgery for pituitary adenoma. Invest Ophthalmol Vis Sci 51:3405-410 CrossRef
  27. Patino CM, Varma R, Azen SP, Conti DV, Nichol MB, McKean-Cowdin R, Los Angeles Latino Eye Study Group (2011) The impact of change in visual field on health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology 118:1310-317
  28. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279-286 CrossRef
  29. van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, Szabó BG, Langendijk JA, Wolffenbuttel BH, Dullaart RP (2007) Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67:863-69 CrossRef
  30. von Baeyer CL, Spagrud LJ, McCormick JC, Choo E, Neville K, Connelly MA (2009) Three new datasets supporting use of the numerical rating scale (NRS-11) for children’s self-reports of pain intensity. Pain 143:223-27 CrossRef
  31. Ware JE (2000) SF-36 health survey update. Spine 15:3130-139 CrossRef
  32. Williamson A, Hoggart B (2005) Pain: a review of three commonly used pain rating scales. J Clin Nurs 14:798-04 CrossRef
  33. Yarushkina NI (2008) The role of hypothalamo-hypophyseal-adrenocortical system hormones in controlling pain sensitivity. Neurosci Behav Physiol 38:759- CrossRef
  
• 作者单位：Eriko Tanemura (1)
  Tetsuya Nagatani (1)
  Yuri Aimi (2)
  Yugo Kishida (3)
  Kazuhito Takeuchi (1)
  Toshihiko Wakabayashi (1)
  
  1. Department of Neurosurgery, Nagoya University, Graduate School of Medicine, 65 Tsurumai Showa-ku, Nagoya City, 466-8550, Japan
  2. Department of Neurosurgery, Yokkaichi Municipal Hospital, Yokkaichi, Japan
  3. Department of Neurosurgery, Fukushima Medical University, School of Medicine, Fukushima, Japan
  

文摘

Background Nonfunctioning pituitary macroadenoma (NFMA) is a benign neoplasm that causes visual function disturbances and headaches and can be treated by transsphenoidal surgery (TSS). It is unclear how quality of life (QOL) changes with surgery and which QOL factors are affected by treatment. Methods The aim is to assess the temporal transition of QOL in NFMA patients undergoing TSS and to identify influential factors. The QOL of NFMA patients who underwent endoscopic TSS was investigated with the short-form 36 (SF-36) health survey questionnaire, general health questionnaire 30 (GHQ30), and numerical rating scale (NRS) of pain at the following three time points: immediately before, 1?month after, and 6?months after surgery. Results Twenty-four of 30 patients had visual deterioration. The SF-36 baseline value of visual function-impaired NFMA patients was lower than that of the normal population. SF-36 results showed that physical summary scores decreased at 1?month after the operation, but recovered up to the normal population level by 6?months. Mental summary scores generally increased at 1?month after surgery and remained stable until 6?months later. The GHQ30 results were similar to the SF-36 mental summary scores. The strongest factor related to the QOL was visual function. The amount of pain and the necessity of hormonal replacement were also influencing factors. Conclusions The QOL of NFMA patients is affected both physically and mentally by surgical treatment and symptoms. This QOL assessment is important for planning treatment strategies.